Dunad - Pioneering a novel generation of covalent medicines

Dunad has developed a plug-and-play platform that utilizes proprietary electrophilic warheads to form a covalent bond and induce irreversible topological modification of disease-causing and often undruggable proteins. Leveraging this technology, the company has identified highly potent and selective small molecules that are orally bioavailable and show optimal drug-like properties.